Skip to content

Clinical trials

Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Status: Unknown status Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20025
20031
20042
20051
20061
20071
20082
20092
20113
20123
20131
20143
20152
20162
20172
20182
20191
20213
20223
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Auxilio Mutuo Cancer Center2
Colorado Blood Cancer Institute2
Gruppo Italiano Malattie EMatologiche dell'Adulto2
Herbert Irving Comprehensive Cancer Center2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2
Medical College of Wisconsin2
Sun Yat-sen University2
Armaceutica, Inc.1
Asan Medical Center1
Cardiff University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma52
Lymphoma17
Burkitt Lymphoma14
Leukemia12
Lymphoma, Follicular12
Lymphoma, Non-Hodgkin12
Leukemia, Myeloid, Acute11
Lymphoma, Large B-Cell, Diffuse11
Leukemia, Lymphocytic, Chronic, B-Cell10
Lymphoma, Large-Cell, Immunoblastic9

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.